IPO7 and neoplasm: This profile of IPO7 and miR-7-5p regulation, which is consistent across high-risk (PTC) and low-risk (NIFTP) neoplasms, suggests that upregulation of IPO7 and downregulation of miR-7-5p are involved in neoplastic transformation rather than in the progression of thyroid tumors.